) has been revised to $4.08 / share. This is a decrease of 20.00% from the prior estimate of $5.10 dated November 14, 2025. The price target is an average of many targets provided by analysts. The ...
An announcement from Century Therapeutics ( ($IPSC) ) is now available. On December 18, 2025, Century Therapeutics, Inc. announced that board ...
Century Therapeutics (NASDAQ:IPSC – Free Report) had its target price cut by HC Wainwright from $5.00 to $2.00 in a research report report published on Thursday morning,Benzinga reports. They ...